Following our previous finding of increased hepatic HIF-2α in patients with NASH living at high altitudes, we hypothesised that HIF-2α may play an additional role in NAFLD and NASH progression. This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatohepatitis.